NCT06530069 Exploring the Risk Factors of Otomycosis: A Case-Control Study
| NCT ID | NCT06530069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhongshan Hospital Xiamen University |
| Condition | Otomycosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2024-08-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-08-01 with a primary completion date of 2024-08-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to explore the risk factors of fungal otitis externa in the fungal otitis externa patients The main question it aims to answer is: What behaviors lead to the occurrence of fungal otitis externa? Participants will complete a detailed questionnaire survey. If there is a comparison group: Researchers will compare the healthy group and the disease group to see if there are any differences.
Eligibility Criteria
Inclusion Criteria: * Symptoms in the case group include tinnitus, ear fullness or blockage, itching, ear pain, discharge, and hearing loss. Physical examination reveals the presence of hyphae, scabs, secretions, masses, pus, red skin, erosion, swelling, or granulation in the ear canal. Laboratory fungal cultures must be positive. The control group does not have the aforementioned ear symptoms and has not sought medical attention for ear-related symptoms. Exclusion Criteria: * Patients with otitis media, tympanic membrane perforation, or post-radiotherapy.
Contact & Investigator
Chunsheng Ye, MD
PRINCIPAL INVESTIGATOR
Zhongshan Hospital Xiamen University
Frequently Asked Questions
Who can join the NCT06530069 clinical trial?
This trial is open to participants of all sexes, studying Otomycosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06530069 currently recruiting?
Yes, NCT06530069 is actively recruiting participants. Contact the research team at 578881502@qq.com for enrollment information.
Where is the NCT06530069 trial being conducted?
This trial is being conducted at Xiamen, China.
Who is sponsoring the NCT06530069 clinical trial?
NCT06530069 is sponsored by Zhongshan Hospital Xiamen University. The principal investigator is Chunsheng Ye, MD at Zhongshan Hospital Xiamen University. The trial plans to enroll 200 participants.